-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Immunocore Holdings plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q3 2024.
- Immunocore Holdings plc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$2.64M, a 1410% decline year-over-year.
- Immunocore Holdings plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$6.71M.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2023 was -$5.6M, a 148% decline from 2022.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2022 was $11.7M, a 7673% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)